{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:43:12Z","timestamp":1777394592958,"version":"3.51.4"},"reference-count":91,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,9,6]]},"DOI":"10.3233\/jad-160324","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T10:25:45Z","timestamp":1470133545000},"page":"417-425","source":"Crossref","is-referenced-by-count":10,"title":["Adenosine Type A2A Receptor in Peripheral Cell from Patients with Alzheimer\u2019s Disease, Vascular Dementia, and Idiopathic Normal Pressure Hydrocephalus: A\u00a0New\/Old Potential Target"],"prefix":"10.1177","volume":"54","author":[{"given":"Beatrice","family":"Arosio","sequence":"first","affiliation":[{"name":"Geriatric Unit, Department of Medical Sciences and Community Health, University of Milan, Milan, Italy"},{"name":"Fondazione Ca\u2019 Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Casati","sequence":"additional","affiliation":[{"name":"Geriatric Unit, Department of Medical Sciences and Community Health, University of Milan, Milan, Italy"},{"name":"Nutritional Sciences, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Gussago","sequence":"additional","affiliation":[{"name":"Geriatric Unit, Department of Medical Sciences and Community Health, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Ferri","sequence":"additional","affiliation":[{"name":"Geriatric Unit, Department of Medical Sciences and Community Health, University of Milan, Milan, Italy"},{"name":"Nutritional Sciences, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Abbate","sequence":"additional","affiliation":[{"name":"Fondazione Ca\u2019 Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Scortichini","sequence":"additional","affiliation":[{"name":"Fondazione Ca\u2019 Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Colombo","sequence":"additional","affiliation":[{"name":"Geriatric Unit, Department of Medical Sciences and Community Health, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo Dionigi","family":"Rossi","sequence":"additional","affiliation":[{"name":"Fondazione Ca\u2019 Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Mari","sequence":"additional","affiliation":[{"name":"Geriatric Unit, Department of Medical Sciences and Community Health, University of Milan, Milan, Italy"},{"name":"Fondazione Ca\u2019 Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-160324_ref1","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.neuron.2014.05.044","article-title":"The cost of brain diseases: A burden or a challenge?","volume":"82","author":"DiLuca","year":"2014","journal-title":"Neuron"},{"issue":"(Suppl 3)","key":"10.3233\/JAD-160324_ref2","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.3233\/JAD-2012-112216","article-title":"The Alzheimer myth and biomarker research in dementia","volume":"31","author":"Richard","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160324_ref3","first-page":"564","article-title":"The comparison of selected cerebrospinal fluid and serum cytokine levels in patients with multiple sclerosis and normal pressure hydrocephalus","volume":"36","author":"Sosvorova","year":"2015","journal-title":"Neuro Endocrinol Lett"},{"key":"10.3233\/JAD-160324_ref4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/1673-5374.152370","article-title":"The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer\u2019s disease: Agonists or antagonists?","volume":"10","author":"Marzagalli","year":"2015","journal-title":"Neural Regen Res"},{"key":"10.3233\/JAD-160324_ref5","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00018-007-6497-0","article-title":"Purine and pyrimidine receptors","volume":"64","author":"Burnstock","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-160324_ref6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.00043.2006","article-title":"Physiology and pathophysiology of purinergic neurotransmission","volume":"87","author":"Burnstock","year":"2007","journal-title":"Physiol Rev"},{"key":"10.3233\/JAD-160324_ref7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-201X.2007.01689.x","article-title":"G-protein-coupled receptors: An update","volume":"190","author":"Fredholm","year":"2007","journal-title":"Acta Physiol"},{"key":"10.3233\/JAD-160324_ref8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev.pharmtox.41.1.775","article-title":"Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection","volume":"41","author":"Linden","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.3233\/JAD-160324_ref9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/157015909789152128","article-title":"Tuning and fine-tuning of synapses with adenosine","volume":"7","author":"Sebastiao","year":"2009","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-160324_ref10","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.4049\/jimmunol.135.2.1366","article-title":"Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils","volume":"135","author":"Cronstein","year":"1985","journal-title":"J Immunol"},{"key":"10.3233\/JAD-160324_ref11","doi-asserted-by":"crossref","first-page":"25881","DOI":"10.1074\/jbc.272.41.25881","article-title":"Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells","volume":"272","author":"Koshiba","year":"1997","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160324_ref12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.it.2005.04.004","article-title":"The \u2018danger\u2019 sensors that STOP the immune response: The A2 adenosine receptors?","volume":"26","author":"Sitkovsky","year":"2005","journal-title":"Trends Immunol"},{"key":"10.3233\/JAD-160324_ref13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pneurobio.2007.09.002","article-title":"Adenosine A2A receptors and brain injury: Broad spectrum of neuroprotection, multifaceted actions and \u201cfine tuning\u201d modulation","volume":"83","author":"Chen","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-160324_ref14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0006-2952(02)01548-4","article-title":"Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo","volume":"65","author":"Sitkovsky","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-160324_ref15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.22.012703.104731","article-title":"Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors","volume":"22","author":"Sitkovsky","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.3233\/JAD-160324_ref16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-3-540-89615-9_16","article-title":"Adenosine receptors and the central nervous system.","author":"Sebastiao","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.3233\/JAD-160324_ref17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/978-3-540-89615-9_17","article-title":"Adenosine receptors and neurological disease: Neuroprotection and neurodegeneration.","author":"Stone","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.3233\/JAD-160324_ref18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3233\/JAD-2010-090814","article-title":"Adenosine A2A receptor expression in peripheral blood mononuclear cells of patients with mild cognitive impairment","volume":"20","author":"Arosio","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160324_ref19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-131652","article-title":"Different adenosine A2A receptor expression in peripheral cells from elderly patients with vascular dementia and Alzheimer\u2019s disease","volume":"40","author":"Gussago","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160324_ref20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jns.2015.12.040","article-title":"Down-regulation of adenosine A1 and A2A receptors in peripheral cells from idiopathic normal-pressure hydrocephalus patients","volume":"361","author":"Casati","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-160324_ref21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","article-title":"Epidemiology of Alzheimer disease","volume":"7","author":"Reitz","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-160324_ref22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/02646830500382037","article-title":"Clinical aspects of inflammation in Alzheimer\u2019s disease","volume":"17","author":"Rosenberg","year":"2005","journal-title":"Int Rev Psychiatry"},{"key":"10.3233\/JAD-160324_ref23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.expneurol.2012.10.007","article-title":"Astrocytes: Conductors of the Alzheimer disease neuroinflammatory symphony","volume":"239","author":"Medeiros","year":"2013","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-160324_ref24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tins.2011.10.002","article-title":"Prion protein at the crossroads of physiology and disease","volume":"35","author":"Biasini","year":"2012","journal-title":"Trends Neurosci"},{"key":"10.3233\/JAD-160324_ref25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.freeradbiomed.2012.09.016","article-title":"Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis","volume":"62","author":"Dasuri","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/JAD-160324_ref26","doi-asserted-by":"crossref","first-page":"292598","DOI":"10.1155\/2012\/292598","article-title":"Cholesterol: Its regulation and role in central nervous system disorders","volume":"2012","author":"Orth","year":"2012","journal-title":"Cholesterol"},{"key":"10.3233\/JAD-160324_ref27","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.3390\/ijms131012629","article-title":"The role of glucose transporters in brain disease: Diabetes and Alzheimer\u2019s disease","volume":"13","author":"Shah","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-160324_ref28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11302-005-0649-1","article-title":"Neuroprotection by adenosine in the brain: From A(1) recetor activation to A (2A) receptor blockade","volume":"1","author":"Cunha","year":"2005","journal-title":"Purinergic Signal"},{"key":"10.3233\/JAD-160324_ref29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbr.2004.10.017","article-title":"Blockade of adenosine A2A receptors reverses short-term social memory impairments in spontaneously hypertensive rats","volume":"159","author":"Prediger","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-160324_ref30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.expneurol.2006.08.008","article-title":"Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice","volume":"203","author":"Dall\u2019Igna","year":"2007","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-160324_ref31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuroscience.2006.07.021","article-title":"Caffeine protects Alzheimer\u2019s mice against cognitive impairment and reduces brain beta-amyloid production","volume":"142","author":"Arendash","year":"2006","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-160324_ref32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ejcn.1602495","article-title":"Coffee consumption is inversely associated with cognitive decline in elderly European men: The FINE Study","volume":"61","author":"van Gelder","year":"2007","journal-title":"Eur J Clin Nutr"},{"key":"10.3233\/JAD-160324_ref33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/aje\/kwf074","article-title":"Risk factors for Alzheimer\u2019s disease: A prospective analysis from the Canadian Study of Health and Aging","volume":"156","author":"Lindsay","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.3233\/JAD-160324_ref34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JAD-2009-0920","article-title":"Midlife coffee and tea drinking and the risk of late-life dementia: A population-based CAIDE study","volume":"16","author":"Eskelinen","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160324_ref35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3233\/JAD-2012-111781","article-title":"High blood caffeine levels in MCI linked to lack of progression to dementia","volume":"30","author":"Cao","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160324_ref36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hup.218","article-title":"Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups","volume":"15","author":"Hameleers","year":"2000","journal-title":"Hum Psychopharmacol"},{"key":"10.3233\/JAD-160324_ref37","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0091-3057(03)00171-0","article-title":"The effects of habitual caffeine use on cognitive change: A longitudinal perspective","volume":"75","author":"van Boxtel","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3233\/JAD-160324_ref38","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.wnl.0000266670.35219.0c","article-title":"The neuroprotective effects of caffeine: A prospective population study (the Three City Study)","volume":"69","author":"Ritchie","year":"2007","journal-title":"Neurology"},{"key":"10.3233\/JAD-160324_ref39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3233\/JAD-2010-101428","article-title":"Coffee intake in midlife and risk of dementia and its neuropathologic correlates","volume":"23","author":"Gelber","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160324_ref40","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neuroscience.2005.01.014","article-title":"Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat","volume":"132","author":"Rebola","year":"2005","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-160324_ref41","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.bjp.0705185","article-title":"Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity","volume":"138","author":"Dall\u2019Igna","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.3233\/JAD-160324_ref42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jbspin.2010.08.010","article-title":"Adenosine, inflammation pathways and therapeutic challenges","volume":"78","author":"Csoka","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.3233\/JAD-160324_ref43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/rns.2011.020","article-title":"Adenosine 2A receptor: A crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury","volume":"22","author":"Dai","year":"2011","journal-title":"Rev Neurosci"},{"key":"10.3233\/JAD-160324_ref44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/mp.2015.115","article-title":"A2A adenosine receptor deletion is protective in a mouse model of Tauopathy","volume":"21","author":"Laurent","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-160324_ref45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/B978-0-12-801022-8.00012-X","article-title":"Adenosine receptor control of cognition in normal and disease","volume":"119","author":"Chen","year":"2014","journal-title":"Int Rev Neurobiol"},{"key":"10.3233\/JAD-160324_ref46","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1056\/NEJMoa0806142","article-title":"Age, neuropathology, and dementia","volume":"360","author":"Savva","year":"2009","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-160324_ref47","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-160324_ref48","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"issue":"(Suppl 1)","key":"10.3233\/JAD-160324_ref49","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1007\/s10072-006-0545-7","article-title":"Vascular dementia","volume":"27","author":"Micieli","year":"2006","journal-title":"Neurol Sci"},{"key":"10.3233\/JAD-160324_ref50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1179\/016164103101201968","article-title":"Comparison between Alzheimer\u2019s disease and vascular dementia: Implications for treatment","volume":"25","author":"Kalaria","year":"2003","journal-title":"Neurol Res"},{"key":"10.3233\/JAD-160324_ref51","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.wad.0000213803.82058.46","article-title":"Targeting cell death in dementia","volume":"20","author":"Francis","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-160324_ref52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jns.2004.11.028","article-title":"Understanding regulation of nerve cell death by mGluRs as a method for development of successful neuroprotective strategies","volume":"229-230","author":"Baskys","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-160324_ref53","first-page":"327","article-title":"Vascular dementia: Pharmacological treatment approaches and perspectives","volume":"2","author":"Baskys","year":"2007","journal-title":"Clin Interv Aging"},{"key":"10.3233\/JAD-160324_ref54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2015.11.007","article-title":"Purinergic signalling in brain ischemia","volume":"104","author":"Pedata","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-160324_ref55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1471-4159.2001.00274.x","article-title":"gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia","volume":"77","author":"Schwartz-Bloom","year":"2001","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-160324_ref56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0006-8993(92)90312-W","article-title":"Adenosine receptor agonists inhibit the release of gamma-aminobutyric acid (GABA) from the ischemic rat cerebral cortex","volume":"582","author":"O\u2019Regan","year":"1992","journal-title":"Brain Res"},{"key":"10.3233\/JAD-160324_ref57","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11064-005-2682-4","article-title":"GABA release modified by adenosine receptors in mouse hippocampal slices under normal and ischemic conditions","volume":"30","author":"Saransaari","year":"2005","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-160324_ref58","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1615\/CritRevNeurobiol.v16.i4.20","article-title":"Adenosine and adenine nucleotides as regulators of cerebral blood flow: Roles of acidosis, cell swelling, and KATP channels","volume":"16","author":"Phillis","year":"2004","journal-title":"Crit Rev Neurobiol"},{"key":"10.3233\/JAD-160324_ref59","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd2638","article-title":"Adenosine receptors: Therapeutic aspects for inflammatory and immune diseases","volume":"7","author":"Hasko","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-160324_ref60","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1227\/01.NEU.0000168185.29659.C5","article-title":"Diagnosing idiopathic normal-pressure hydrocephalus","volume":"57","author":"Relkin","year":"2005","journal-title":"Neurosurgery"},{"key":"10.3233\/JAD-160324_ref61","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0404.2009.01250.x","article-title":"Five-year incidence of surgery for idiopathic normal pressure hydrocephalus in Norway","volume":"120","author":"Brean","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-160324_ref62","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000000342","article-title":"Prevalence of idiopathic normal-pressure hydrocephalus","volume":"82","author":"Jaraj","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-160324_ref63","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jns.2008.10.004","article-title":"Asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus on MRI (AVIM) in the elderly: A prospective study in a Japanese population","volume":"277","author":"Iseki","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-160324_ref64","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jns.2013.02.020","article-title":"Predictors of the disappearance of triad symptoms in patients with idiopathic normal pressure hydrocephalus after shunt surgery","volume":"328","author":"Kazui","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-160324_ref65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/NEU.0b013e31827414b3","article-title":"Poor cognitive outcome in shunt-responsive idiopathic normal pressure hydrocephalus","volume":"72","author":"Koivisto","year":"2013","journal-title":"Neurosurgery"},{"key":"10.3233\/JAD-160324_ref66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000347147","article-title":"Association between milder brain deformation before a shunt operation and improvement in cognition and gait in idiopathic normal pressure hydrocephalus","volume":"35","author":"Yamamoto","year":"2013","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-160324_ref67","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2990.2011.01195.x","article-title":"Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature","volume":"38","author":"Leinonen","year":"2012","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-160324_ref68","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2045-8118-11-19","article-title":"Increased prevalence of cardiovascular disease in idiopathic normal pressure hydrocephalus patients compared to a population-based cohort from the HUNT3 survey","volume":"11","author":"Eide","year":"2014","journal-title":"Fluids Barriers CNS"},{"key":"10.3233\/JAD-160324_ref69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2006.11.039","article-title":"Expression of TGF-betas and TGF-beta type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus","volume":"413","author":"Li","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-160324_ref70","doi-asserted-by":"crossref","first-page":"e91974","DOI":"10.1371\/journal.pone.0091974","article-title":"Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus","volume":"9","author":"Pyykko","year":"2014","journal-title":"PloS One"},{"issue":"(Suppl 2)","key":"10.3233\/JAD-160324_ref71","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.33549\/physiolres.933069","article-title":"The impact of selected cytokines in the follow-up of normal pressure hydrocephalus","volume":"64","author":"Sosvorova","year":"2015","journal-title":"Physiol Res"},{"key":"10.3233\/JAD-160324_ref72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0531-5565(00)00176-5","article-title":"Patients with Alzheimer\u2019s disease display a pro-inflammatory phenotype","volume":"36","author":"Remarque","year":"2001","journal-title":"Exp Gerontol"},{"issue":"(Suppl 3)","key":"10.3233\/JAD-160324_ref73","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1016\/S1353-8020(09)70813-2","article-title":"Differential regulation of microglial motility by ATP\/ADP and adenosine","volume":"15","author":"Gyoneva","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-160324_ref74","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1213\/ane.0b013e318173251f","article-title":"Expression of adenosine A 2A receptors in the rat lumbar spinal cord and implications in the modulation of N-methyl-d-aspartate receptor currents","volume":"106","author":"Guntz","year":"2008","journal-title":"Anesth Analg"},{"key":"10.3233\/JAD-160324_ref75","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2174\/138161208785740018","article-title":"The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases","volume":"14","author":"Centonze","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.3233\/JAD-160324_ref76","doi-asserted-by":"crossref","first-page":"169203","DOI":"10.1155\/2014\/169203","article-title":"Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly","volume":"2014","author":"Arosio","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.3233\/JAD-160324_ref77","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(99)00046-6","article-title":"Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer\u2019s Disease (AD) individuals","volume":"97","author":"Lombardi","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.3233\/JAD-160324_ref78","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000333799","article-title":"Pin1 contribution to Alzheimer\u2019s disease: Transcriptional and epigenetic mechanisms in patients with late-onset Alzheimer\u2019s disease","volume":"10","author":"Arosio","year":"2012","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-160324_ref79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-130506","article-title":"Involvement of 5-lipoxygenase in Alzheimer\u2019s disease: A role for DNA methylation","volume":"37","author":"Di Francesco","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160324_ref80","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbi.2014.11.002","article-title":"Global changes in DNA methylation in Alzheimer\u2019s disease peripheral blood mononuclear cells","volume":"45","author":"Di Francesco","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JAD-160324_ref81","doi-asserted-by":"crossref","unstructured":"Lehallier B , Essioux L , Gayan J , Alexandridis R , Nikolcheva T , Wyss-Coray T , Britschgi M (2015) Combined plasma and cerebrospinal fluid signature for the prediction of midterm progression from mild cognitive impairment to Alzheimer disease.. JAMA Neurol, doi: 10.1001\/jamaneurol.2015.3135","DOI":"10.1001\/jamaneurol.2015.3135"},{"key":"10.3233\/JAD-160324_ref82","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1101\/gad.1399806","article-title":"Control of translation and mRNA degradation by miRNAs and siRNAs","volume":"20","author":"Valencia-Sanchez","year":"2006","journal-title":"Genes Dev"},{"key":"10.3233\/JAD-160324_ref83","doi-asserted-by":"crossref","first-page":"13175","DOI":"10.1074\/jbc.M115.712083","article-title":"The dynamics and turnover of tau aggregates in cultured cells: Insights into therapies for tauopathies","volume":"291","author":"Guo","year":"2016","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-160324_ref84","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-3639.2007.00112.x","article-title":"Up-regulation of adenosine receptors in the frontal cortex in Alzheimer\u2019s disease","volume":"18","author":"Albasanz","year":"2008","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-160324_ref85","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1100\/tsw.2011.22","article-title":"Anti-inflammatory and immunosuppressive effects of the A2A adenosine receptor","volume":"11","author":"Milne","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"10.3233\/JAD-160324_ref86","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0306-3623(95)00042-9","article-title":"Adenosine A1 receptor enhancer, PD 81,723, and cerebral ischemia\/reperfusion injury in the gerbil","volume":"26","author":"Cao","year":"1995","journal-title":"Gen Pharmacol"},{"key":"10.3233\/JAD-160324_ref87","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-3565(24)37372-0","article-title":"Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat","volume":"285","author":"Monopoli","year":"1998","journal-title":"J Pharmacol Exp Therapeutics"},{"key":"10.3233\/JAD-160324_ref88","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1097\/00001756-199812010-00034","article-title":"Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats","volume":"9","author":"Monopoli","year":"1998","journal-title":"Neuroreport"},{"key":"10.3233\/JAD-160324_ref89","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/phrs.2001.0918","article-title":"Blockade of A(2A) adenosine receptors leads to c-fos inhibition in a rat model of brain ischemia","volume":"45","author":"Petroni","year":"2002","journal-title":"Pharmacol Res"},{"key":"10.3233\/JAD-160324_ref90","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(95)01153-6","article-title":"The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil","volume":"705","author":"Phillis","year":"1995","journal-title":"Brain Res"},{"key":"10.3233\/JAD-160324_ref91","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0006-8993(98)00540-X","article-title":"Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist","volume":"800","author":"Jones","year":"1998","journal-title":"Brain Res"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-160324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:03:45Z","timestamp":1777370625000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-160324"}},"subtitle":[],"editor":[{"given":"Patrizia","family":"Mecocci","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":91,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-160324","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,6]]}}}